Anycare LLC

Anycare LLC was paid $2.41M by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.

33Billing provider infoANYCARE LLC
LEBANON, TN 37087

33aNPI1780022855assigned 06/11/2013

33bProvider typeClinic/Center

28Total paid$2.41M

24GClaims80,391

24DCodes billed21

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic/Center providers in Tennessee

Rank by total paid#6 of 70

Median peer was paid$72K

This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	9,428	$294K
2019	11,646	$285K
2020	6,976	$244K
2021	9,636	$394K
2022	14,945	$423K
2023	16,639	$464K
2024incomplete	11,121	$312K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	43%	21,171	18,648	$1.05M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	19%	11,711	10,897	$470K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	9.9%	6,922	6,551	$240K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	7.1%	18,204	8,475	$171K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	5.7%	2,501	2,351	$137K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	3.9%	12,109	11,306	$95K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.9%	1,259	1,181	$93K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.6%	2,151	2,023	$63K
87428		<1%	433	422	$23K
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	<1%	40	29	$19K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	431	409	$17K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	52	30	$15K

9 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	281	$11K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	173	$8K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	693	$5K
81003		<1%	1,929	$3K
86328		<1%	39	$1K
85027		<1%	177	$381.34
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	14	$144.22
90756		<1%	12	$50.00
Q0240	Injection, casirivimab and imdevimab, 600 mg	0%	89	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROBERTSON, GEORGE (OWNER/ URGENT CARE PHYSICIAN)